Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2007 | 06-2007 | 03-2007 | 12-2006 | 09-2006 | |
| Sales | 17,018 | 25,457 | 17,637 | 21,935 | 17,848 |
| Gross Profit | 17,018 | 25,457 | 17,637 | 21,935 | 17,848 |
| Operating Expenses | 34,367 | 29,584 | 29,939 | 25,573 | 22,742 |
| Operating Income | -17,349 | -4,127 | -12,302 | -3,638 | -4,894 |
| Other Income | 1,749 | 1,744 | 1,869 | 1,926 | 1,959 |
| Pre-tax Income | -15,600 | -2,383 | -10,433 | -1,712 | -2,935 |
| Net Income Continuous | -15,600 | -2,383 | -10,433 | -1,712 | -2,935 |
| Net Income | $-15,600 | $-2,383 | $-10,433 | $-1,712 | $-2,935 |
| EPS Basic Total Ops | -0.58 | -0.09 | -0.40 | -0.07 | -0.11 |
| EPS Basic Continuous Ops | -0.58 | -0.09 | -0.40 | -0.06 | -0.11 |
| EPS Diluted Total Ops | -0.58 | -0.09 | -0.40 | -0.07 | -0.11 |
| EPS Diluted Continuous Ops | -0.58 | -0.09 | -0.40 | -0.06 | -0.11 |
| EBITDA(a) | $-16,635 | $-3,494 | $-11,859 | $-3,227 | $-4,541 |